醫療研發外包成分股數據 申萬3級
851563.SI (27)
數據更新時間：2023-10-23
"-"表示無或者負數
| 序號 | 股票代碼 | 股票簡稱 | 納入時間 | 申萬1級 | 申萬2級 | 申萬3級 | 價格
|
市盈率
|
市盈率ttm
|
市凈率
|
股息率
|
市值（億元）
|
歸母凈利潤同比增長(06-30)
|
歸母凈利潤同比增長(03-31)
|
營業收入同比增長(06-30)
|
營業收入同比增長(03-31)
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 603456.SH | 九洲藥業 | 2023-07-06 | — | — | 醫療研發外包 | 26.27 | 25.66 | 21.99 | 2.94 | 1.52% | 236.30 | 32.83% | 35.07% | 10.16% | 27.49% |
| 2 | 300363.SZ | 博騰股份 | 2014-02-12 | — | — | 醫療研發外包 | 26.96 | 7.34 | 12.23 | 2.51 | 4.09% | 147.23 | -66.15% | -20.37% | -40.25% | -4.50% |
| 3 | 301520.SZ | 萬邦醫藥 | 2023-10-10 | — | — | 醫療研發外包 | 56.53 | 38.17 | 32.29 | 2.67 | — | 37.69 | 50.23% | — | 53.28% | — |
| 4 | 600721.SH | 百花醫藥 | 2008-01-25 | — | — | 醫療研發外包 | 7.71 | — | — | 4.19 | — | 29.37 | 26.28% | 387.32% | 2.11% | 28.77% |
| 5 | 300149.SZ | 睿智醫藥 | 2010-12-29 | — | — | 醫療研發外包 | 8.1 | 10.69 | — | 1.72 | — | 40.48 | -102.28% | -401.63% | -18.84% | -30.45% |
| 6 | 688238.SH | 和元生物 | 2023-09-25 | — | — | 醫療研發外包 | 8.3 | 137.7 | — | 2.5 | — | 53.74 | -323.70% | -363.00% | -37.92% | -57.89% |
| 7 | 301096.SZ | 百誠醫藥 | 2021-12-27 | — | — | 醫療研發外包 | 64.6 | 35.99 | 30.57 | 2.75 | 1.24% | 69.88 | 40.51% | 79.56% | 72.53% | 67.97% |
| 8 | 301201.SZ | 誠達藥業 | 2022-01-27 | — | — | 醫療研發外包 | 22.76 | 33.07 | 49.77 | 1.59 | 0.82% | 35.21 | -54.91% | -25.10% | -23.31% | -5.91% |
| 9 | 301333.SZ | 諾思格 | 2022-08-09 | — | — | 醫療研發外包 | 62.0 | 52.4 | 43.05 | 3.59 | 0.25% | 59.52 | 40.23% | 7.63% | 11.02% | -5.47% |
| 10 | 301509.SZ | 金凱生科 | 2023-08-10 | — | — | 醫療研發外包 | 74.54 | 39.72 | 36.96 | 3.04 | — | 64.13 | 12.06% | 22.46% | 15.24% | 38.48% |
| 11 | 300347.SZ | 泰格醫藥 | 2012-08-24 | — | — | 醫療研發外包 | 64.4 | 28.0 | 25.5 | 2.73 | 0.85% | 561.84 | 16.47% | 9.65% | 3.25% | -0.73% |
| 12 | 688202.SH | 美迪西 | 2023-09-25 | — | — | 醫療研發外包 | 69.08 | 27.47 | 27.19 | 3.41 | — | 92.92 | 2.17% | 31.58% | 17.43% | 26.80% |
| 13 | 688265.SH | 南模生物 | 2023-09-25 | — | — | 醫療研發外包 | 36.28 | — | — | 1.6 | — | 28.29 | -159.45% | -202.22% | 39.05% | 20.08% |
| 14 | 002821.SZ | 凱萊英 | 2016-11-25 | — | — | 醫療研發外包 | 154.67 | 17.32 | 17.6 | 3.41 | 1.16% | 571.75 | -3.09% | 26.22% | -8.33% | 9.09% |
| 15 | 688131.SH | 皓元醫藥 | 2023-09-25 | — | — | 醫療研發外包 | 60.05 | 46.64 | 52.47 | 3.71 | — | 90.31 | -18.50% | -25.83% | 41.78% | 39.46% |
| 16 | 688076.SH | 諾泰生物 | 2023-09-25 | — | — | 醫療研發外包 | 42.56 | 70.28 | 54.13 | 4.6 | — | 90.73 | 20.15% | 30.57% | 49.38% | 54.98% |
| 17 | 300759.SZ | 康龍化成 | 2019-02-11 | — | — | 醫療研發外包 | 29.07 | 37.79 | 32.97 | 4.58 | 0.69% | 519.40 | 34.28% | 39.81% | 21.70% | 29.53% |
| 18 | 688046.SH | 藥康生物 | 2023-09-25 | — | — | 醫療研發外包 | 15.82 | 39.4 | 40.39 | 3.17 | — | 64.86 | -4.98% | 2.39% | 18.17% | 20.82% |
| 19 | 300404.SZ | 博濟醫藥 | 2015-05-04 | — | — | 醫療研發外包 | 8.2 | 109.66 | 99.78 | 3.45 | 0.12% | 30.34 | 18.16% | -6.03% | 32.73% | 39.25% |
| 20 | 688621.SH | 陽光諾和 | 2023-09-25 | — | — | 醫療研發外包 | 62.29 | 44.74 | 37.4 | 7.22 | — | 69.76 | 35.03% | 43.52% | 42.16% | 57.09% |
| 21 | 300725.SZ | 藥石科技 | 2017-11-17 | — | — | 醫療研發外包 | 42.5 | 27.01 | 30.86 | 3.21 | 0.24% | 84.86 | -25.61% | -18.47% | 14.89% | 14.24% |
| 22 | 301257.SZ | 普蕊斯 | 2022-05-24 | — | — | 醫療研發外包 | 61.9 | 52.28 | 32.94 | 3.78 | 0.17% | 37.86 | 218.86% | 159.52% | 42.20% | 30.02% |
| 23 | 688073.SH | 畢得醫藥 | 2023-09-25 | — | — | 醫療研發外包 | 65.46 | 40.76 | 34.87 | 2.91 | — | 59.49 | 41.63% | 45.22% | 41.76% | 42.58% |
| 24 | 301230.SZ | 泓博醫藥 | 2022-11-08 | — | — | 醫療研發外包 | 38.07 | 60.99 | 51.51 | 3.68 | 0.94% | 40.97 | 60.26% | 47.03% | 15.44% | 16.37% |
| 25 | 603127.SH | 昭衍新藥 | 2017-09-01 | — | — | 醫療研發外包 | 23.87 | 16.66 | 22.55 | 2.23 | 1.2% | 179.00 | -75.58% | 49.79% | 30.27% | 36.32% |
| 26 | 603259.SH | 藥明康德 | 2018-05-15 | — | — | 醫療研發外包 | 84.35 | 28.41 | 26.38 | 5.02 | 1.06% | 2504.08 | 14.61% | 31.97% | 6.28% | 5.77% |
| 27 | 688222.SH | 成都先導 | 2023-09-25 | — | — | 醫療研發外包 | 13.72 | 217.58 | 144.12 | 4.14 | — | 54.97 | 182.47% | -32.52% | 12.21% | -3.99% |
免責聲明：數據相關欄目所收集數據，均來自第三方個人或企業公開數據以及國家統計網站公開發布數據，數據由計算機技術自動收集更新再由作者校驗，作者將盡力校驗，但不能保證數據的完全準確。 閱讀本欄目的用戶必須明白，圖表所示結果或標示僅供學習參考使用，均不構成交易依據。任何據此進行交易等行為，而引致的任何損害后果，本站概不負責。
關注微信公眾號
獲取更多數據
獲取更多數據
關閉 X